Purchase Order 75F40124P00214

The U.S. Food and Drug Administration (FDA) awarded a $50,900 firm-fixed price purchase order to Mouse Specifics Inc., a small business manufacturer of medical devices and equipment for animal research, for a DigiGait Imaging System for treadmill gait analysis in mice. This purchase order supports the FDA's Center for Biologics Evaluation and Research (CBER) in its research on gene therapy in mice with genetic muscle diseases. The contract has a total small business set-aside, and the system must meet specific technical requirements, provide a one-year warranty, and comply with Section 508 accessibility standards. The place of performance is in Framingham, Massachusetts, and the ultimate completion date is September 30, 2024.